Antigen presentation by MHC class II molecules

[1]  R. Germain,et al.  Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules , 1993, Nature.

[2]  A. Goldrath,et al.  T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates , 1995, The Journal of experimental medicine.

[3]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[4]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[5]  H. Geuze,et al.  Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. , 1993, Journal of immunology.

[6]  P. A. Peterson,et al.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.

[7]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[8]  H. Grey,et al.  Isolation and characterization of antigen-la complexes involved in T cell recognition , 1986, Cell.

[9]  P. Jensen,et al.  Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH , 1991, The Journal of experimental medicine.

[10]  P. Cresswell,et al.  In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. , 1994, Immunity.

[11]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[12]  R. Germain,et al.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy , 1994, The Journal of experimental medicine.

[13]  P. Cresswell,et al.  Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. , 1994, Immunity.

[14]  H. Ploegh,et al.  Isolation and characterization of the intracellular MHC class II compartment , 1994, Nature.

[15]  K. Mason,et al.  Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. , 1995, International immunology.

[16]  V. Gnau,et al.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules , 1995, The Journal of experimental medicine.

[17]  J. Trowsdale,et al.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.

[18]  P. Marrack,et al.  Superantigens: mechanism of T-cell stimulation and role in immune responses. , 1991, Annual review of immunology.

[19]  I. Mellman,et al.  Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes , 1994, Nature.

[20]  D. Larhammar,et al.  cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[22]  D. O'Sullivan,et al.  Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation , 1987, The Journal of experimental medicine.

[23]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[24]  P. Cresswell,et al.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. F. Naujokas,et al.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Wandinger-Ness,et al.  Separation of subcellular compartments containing distinct functional forms of MHC class II , 1994, The Journal of cell biology.

[27]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[28]  C. Lee,et al.  A general model of invariant chain association with class II major histocompatibility complex proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[30]  Jeffrey A. Shaman,et al.  An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.

[31]  P. L. Campbell,et al.  Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. , 1994, Journal of immunology.

[32]  A. Chervonsky,et al.  A segment of the MHC class II beta chain plays a critical role in targeting class II molecules to the endocytic pathway. , 1994, International immunology.

[33]  D. Wiley,et al.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[34]  I. Mellman,et al.  The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules , 1994, The Journal of experimental medicine.

[35]  P. Milburn,et al.  A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules. , 1997, International immunology.

[36]  J. H. Brown.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[37]  M. Davis,et al.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[39]  B. Arp,et al.  HLA-DMA and DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994 .

[40]  Mark S. Anderson,et al.  The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.

[41]  P. Jensen,et al.  Regulation of antigen presentation by acidic pH , 1990, The Journal of experimental medicine.

[42]  R. Geha,et al.  MHC class II signaling in B-cell activation. , 1994, Immunology today.

[43]  P. A. Peterson,et al.  Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens , 1982, Cell.

[44]  P. Marrack,et al.  Mutations defining functional regions of the superantigen staphylococcal enterotoxin B , 1992, The Journal of experimental medicine.

[45]  T. Watts,et al.  Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules. , 1995, International immunology.

[46]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[47]  P. Cresswell,et al.  Role for intracellular proteases in the processing and transport of class II HLA antigens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[48]  H. Mcdevitt,et al.  Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates. , 1979, Molecular immunology.

[49]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[50]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[51]  H. Ploegh,et al.  Mapping functional regions in the lumenal domain of the class II- associated invariant chain , 1994, The Journal of experimental medicine.

[52]  N. Koch,et al.  The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Don C. Wiley,et al.  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.

[54]  A. Chervonsky,et al.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent , 1995, The Journal of experimental medicine.

[55]  A. Rudensky,et al.  Intracellular assembly and transport of endogenous peptide-MHC class II complexes. , 1994, Immunity.

[56]  H. Geuze,et al.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route , 1990, Cell.

[57]  M. Taylor,et al.  Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  E. Unanue,et al.  Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Hämmerling,et al.  Self-Release of CLIP in Peptide Loading of HLA-DR Molecules , 1995, Science.

[60]  P. P. Jones,et al.  The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization. , 1981, Molecular immunology.

[61]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[62]  B. Fleischer,et al.  Major histocompatibility complex class II‐associated peptides determine the binding of the superantigen toxic shock syndrome toxin‐1 , 1995, European journal of immunology.

[63]  Antonio Lanzavecchia,et al.  Irreversible association of peptides with class II MHC molecules in living cells , 1992, Nature.

[64]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[65]  J. Trowsdale,et al.  Association between HLA-DM and HLA-DR in vivo. , 1996, Immunity.

[66]  H. Davidson,et al.  Epitope-directed processing of specific antigen by B lymphocytes , 1989, The Journal of cell biology.

[67]  O. Rötzschke,et al.  Origin, structure and motifs of naturally processed MHC class II ligands. , 1994, Current opinion in immunology.

[68]  H. Mcdevitt,et al.  Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[69]  John Trowsdale,et al.  A new human HLA class II-related locus, DM , 1991, Nature.

[70]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[71]  E. Appella,et al.  Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules , 1989, Nature.

[72]  J. Rothbard,et al.  Interactions between Immunogenic Peptides and MHC Proteins , 1991 .

[73]  G. Hämmerling,et al.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Germain,et al.  A role for peptide in determining MHC class II structure , 1991, Nature.

[75]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[76]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[77]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[78]  J. Rothbard,et al.  Interactions between immunogenic peptides and MHC proteins. , 1991, Annual review of immunology.

[79]  H. Grey,et al.  The minimal number of class II MHC-antigen complexes needed for T cell activation. , 1990, Science.

[80]  P. Jensen.  Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization , 1992, The Journal of experimental medicine.

[81]  P. Allen,et al.  Binding to Ia protects an immunogenic peptide from proteolytic degradation. , 1989, Journal of immunology.

[82]  D. Wettstein,et al.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. , 1992, The EMBO journal.

[83]  Patricia P. Jones,et al.  The gene encoding the Ia antigen-associated invariant chain (Ii) is not linked to the H–2 complex , 1983, Nature.

[84]  J. Sidney,et al.  Effect of pH on MHC class II-peptide interactions. , 1992, Journal of immunology.

[85]  I. Mellman,et al.  Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity , 1989, Cell.

[86]  P. Cresswell,et al.  Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. , 1994, International immunology.

[87]  E. Unanue,et al.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[88]  L. Smith,et al.  A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides , 1994, The Journal of experimental medicine.

[89]  D. Wiley,et al.  Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. , 1994, Science.

[90]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[91]  O. Bakke,et al.  Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. , 1993, International immunology.

[92]  M. Brenner,et al.  Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. , 1994, International immunology.

[93]  H. Ploegh,et al.  Generation, translocation, and presentation of MHC class I-restricted peptides. , 1995, Annual review of biochemistry.

[94]  C. Watts,et al.  Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells , 1994, Nature.

[95]  R. Sékaly,et al.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. , 1996, The EMBO journal.

[96]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[97]  S. Pierce,et al.  Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. , 1994, Immunity.

[98]  L. Smith,et al.  A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex , 1991, The Journal of experimental medicine.

[99]  P. Marrack,et al.  Superantigens and their potential role in human disease. , 1993, Advances in immunology.

[100]  A. Lanzavecchia,et al.  Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.

[101]  L. Hood,et al.  Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide , 1981, The Journal of experimental medicine.

[102]  B. Arp,et al.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes , 1990, Nature.

[103]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[104]  J. Strominger,et al.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH , 1994, The Journal of experimental medicine.

[105]  M. Davis,et al.  Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH , 1991, The Journal of experimental medicine.

[106]  C. Benoist,et al.  Mice lacking the MHC class II-associated invariant chain , 1993, Cell.

[107]  C. Watts,et al.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments , 1990, Nature.

[108]  Jim Miller,et al.  Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41 , 1992, Nature.